Journal of Clinical Investigation,
Год журнала:
2021,
Номер
131(1)
Опубликована: Янв. 3, 2021
Carbohydrate
restriction,
used
since
the
1700s
to
prolong
survival
in
people
with
diabetes,
fell
out
of
favor
after
discovery
insulin.
Despite
costly
pharmacological
and
technological
developments
last
few
decades,
current
therapies
do
not
achieve
optimal
outcomes,
most
diabetes
remain
at
high
risk
for
micro-
macrovascular
complications.
Recently,
low-carbohydrate
diets
have
regained
popularity,
preliminary
evidence
benefit
body
weight,
postprandial
hyperglycemia,
hyperinsulinemia,
other
cardiometabolic
factors
type
2
and,
more
limited
data,
1
diabetes.
High-quality,
long-term
trials
are
needed
assess
safety
concerns
determine
whether
this
old
dietary
approach
might
help
attain
clinical
targets
effectively,
a
lower
cost,
than
conventional
treatment.
Signal Transduction and Targeted Therapy,
Год журнала:
2022,
Номер
7(1)
Опубликована: Янв. 17, 2022
The
ketogenic
diet
(KD)
is
a
high-fat,
adequate-protein,
and
very-low-carbohydrate
regimen
that
mimics
the
metabolism
of
fasting
state
to
induce
production
ketone
bodies.
KD
has
long
been
established
as
remarkably
successful
dietary
approach
for
treatment
intractable
epilepsy
increasingly
garnered
research
attention
rapidly
in
past
decade,
subject
emerging
evidence
promising
therapeutic
potential
various
diseases,
besides
epilepsy,
from
obesity
malignancies.
In
this
review,
we
summarize
experimental
and/or
clinical
efficacy
safety
different
discuss
possible
mechanisms
action
based
on
recent
advances
understanding
influence
at
cellular
molecular
levels.
We
emphasize
may
function
through
multiple
mechanisms,
which
remain
be
further
elucidated.
challenges
future
directions
implementation
spectrum
diseases
have
discussed.
suggest
that,
with
encouraging
effects
increasing
insights
into
action,
randomized
controlled
trials
should
conducted
elucidate
foundation
use
KD.
Abstract
During
starvation,
fasting,
or
a
diet
containing
little
digestible
carbohydrates,
the
circulating
insulin
levels
are
decreased.
This
promotes
lipolysis,
and
breakdown
of
fat
becomes
major
source
energy.
The
hepatic
energy
metabolism
is
regulated
so
that
under
these
circumstances,
ketone
bodies
generated
from
β-oxidation
fatty
acids
secreted
as
ancillary
fuel,
in
addition
to
gluconeogenesis.
Increased
plasma
thus
indicate
dietary
shortage
carbohydrates.
Ketone
not
only
serve
fuel
but
also
promote
resistance
oxidative
inflammatory
stress,
there
decrease
anabolic
insulin-dependent
expenditure.
It
has
been
suggested
beneficial
non-metabolic
actions
on
organ
functions
mediated
by
them
acting
ligand
specific
cellular
targets.
We
propose
here
role
different
pathway
initiated
induction
stress
mitochondria
during
increased
ketolysis.
Oxidative
induced
body
long
term
because
it
initiates
an
adaptive
(hormetic)
response
characterized
activation
master
regulators
cell-protective
mechanism,
nuclear
factor
erythroid
2-related
2
(Nrf2),
sirtuins,
AMP-activated
kinase.
results
resolving
upregulation
anti-oxidative
anti-inflammatory
activities,
improved
mitochondrial
function
growth,
DNA
repair,
autophagy.
In
heart,
enhanced
ketolysis
improves
damage
after
ischemic
insults
cardiotoxic
doxorubicin.
Sodium-dependent
glucose
co-transporter
(SGLT2)
inhibitors
may
exert
their
cardioprotective
action
via
increasing
conclude
synthesis
use
periods
deficient
food
supply
low
causes
latter
protective
which
allows
cells
cope
with
lower
availability.
Keywords
Ketogenic
diet,
bodies,
Beta
hydroxybutyrate,
Insulin,
Obesity,
Type
diabetes,
Inflammation,
Cardiovascular
disease,
SGLT2,
Hormesis
JAMA,
Год журнала:
2023,
Номер
330(20), С. 2000 - 2000
Опубликована: Ноя. 28, 2023
Importance
Obesity
affects
approximately
42%
of
US
adults
and
is
associated
with
increased
rates
type
2
diabetes,
hypertension,
cardiovascular
disease,
sleep
disorders,
osteoarthritis,
premature
death.
Observations
A
body
mass
index
(BMI)
25
or
greater
commonly
used
to
define
overweight,
a
BMI
30
obesity,
lower
thresholds
for
Asian
populations
(BMI
≥25-27.5),
although
use
alone
not
recommended
determine
individual
risk.
Individuals
obesity
have
higher
incident
disease.
In
men
39,
event
are
20.21
per
1000
person-years
compared
13.72
in
normal
BMI.
women
39.9,
9.97
6.37
Among
people
5%
10%
weight
loss
improves
systolic
blood
pressure
by
about
3
mm
Hg
those
may
decrease
hemoglobin
1c
0.6%
1%
diabetes.
Evidence-based
treatment
includes
interventions
addressing
5
major
categories:
behavioral
interventions,
nutrition,
physical
activity,
pharmacotherapy,
metabolic/bariatric
procedures.
Comprehensive
care
plans
combine
appropriate
patients.
Multicomponent
ideally
consisting
at
least
14
sessions
6
months
promote
lifestyle
changes,
including
components
such
as
self-monitoring,
dietary
activity
counseling,
problem
solving,
often
produce
loss,
regain
occurs
25%
more
participants
2-year
follow-up.
Effective
nutritional
approaches
focus
on
reducing
total
caloric
intake
strategies
based
patient
preferences.
Physical
without
calorie
reduction
typically
causes
less
(2-3
kg)
but
important
weight-loss
maintenance.
Commonly
prescribed
medications
antidepressants
(eg,
mirtazapine,
amitriptyline)
antihyperglycemics
glyburide
insulin
cause
gain,
clinicians
should
review
consider
alternatives.
Antiobesity
nonpregnant
patients
overweight
weight-related
comorbidities
conjunction
modifications.
Six
currently
approved
the
Food
Drug
Administration
long-term
use:
glucagon-like
peptide
receptor
1
(GLP-1)
agonists
(semaglutide
liraglutide
only),
tirzepatide
(a
glucose-dependent
insulinotropic
polypeptide/GLP-1
agonist),
phentermine-topiramate,
naltrexone-bupropion,
orlistat.
Of
these,
has
greatest
effect,
mean
21%
72
weeks.
Endoscopic
procedures
(ie,
intragastric
balloon
endoscopic
sleeve
gastroplasty)
can
attain
13%
months.
Weight
from
metabolic
bariatric
surgeries
laparoscopic
gastrectomy
Roux-en-Y
gastric
bypass)
ranges
30%
12
Maintaining
difficult,
clinical
guidelines
support
antiobesity
when
maintenance
inadequate
alone.
Conclusion
Relevance
US.
Behavioral
GLP-1
8%
surgery
loss.
Comprehensive,
evidence-based
combines
Nutrients,
Год журнала:
2021,
Номер
13(5), С. 1442 - 1442
Опубликована: Апрель 24, 2021
NAFLD
is
the
world's
most
common
chronic
liver
disease,
and
its
increasing
prevalence
parallels
global
rise
in
diabetes
obesity.
It
characterised
by
fat
accumulation
evolving
to
non-alcoholic
steatohepatitis
(NASH),
an
inflammatory
subtype
that
can
lead
fibrosis
cirrhosis.
Currently,
there
no
effective
pharmacotherapeutic
treatment
for
NAFLD.
Treatment
therefore
based
on
lifestyle
modifications
including
changes
diet
exercise,
although
it
unclear
what
form
of
intervention
is.
The
aim
this
review,
then,
discuss
role
specific
nutrients
effects
different
dietary
interventions
well
established
unhealthy
rich
calories,
sugars,
saturated
fats
low
polyunsaturated
fatty
acids,
fibre,
micronutrients
plays
a
critical
development
progression
disease.
However,
few
clinical
trials
have
evaluated
nutrition
We,
therefore,
summarise
currently
known
about
macronutrients,
foods,
patterns
prevention
treatment.
Most
current
guidelines
recommend
low-calorie,
plant-based
diets,
such
as
Mediterranean
diet,
pattern
treat
More
are
required,
however,
identify
best
evidence-based
approach.
Nutrients,
Год журнала:
2022,
Номер
14(23), С. 5003 - 5003
Опубликована: Ноя. 24, 2022
Over
a
hundred
years
of
study
on
the
favourable
effect
ketogenic
diets
in
treatment
epilepsy
have
contributed
to
long-lasting
discussion
its
potential
influence
other
neurological
diseases.
A
significant
increase
number
scientific
studies
that
field
has
been
currently
observed.
The
aim
this
paper
is
widespread,
thorough
analysis
available
evidence
respect
role
diet
therapy
diseases
such
as:
epilepsy,
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
multiple
sclerosis
(MS)
and
migraine.
wide
range
mechanisms
action
demonstrated
diseases,
including,
among
effects,
reduction
inflammatory
conditions
amount
reactive
oxygen
species
(ROS),
restoration
myelin
sheath
neurons,
formation
regeneration
mitochondria,
neuronal
metabolism,
provision
an
alternative
source
energy
for
neurons
(ketone
bodies),
glucose
insulin
concentrations,
amyloid
plaques,
induction
autophagy,
alleviation
microglia
activation,
excessive
modulation
intestinal
microbiota,
expression
genes,
dopamine
production
glutamine
conversion
into
GABA.
discussed
(including
randomised
controlled
studies),
conducted
patients,
stressed
effectiveness
promising
therapeutic
frequent
advantage
was
over
non-ketogenic
(in
control
groups)
with
simultaneous
safety
feasibility
when
conducting
nutritional
model.
Vascular Health and Risk Management,
Год журнала:
2023,
Номер
Volume 19, С. 237 - 253
Опубликована: Апрель 1, 2023
Purpose
of
Review:
The
relationship
between
cardiovascular
health
and
diet
is
evolving.
Lifestyle
modifications
including
changes
are
the
primary
approach
in
managing
cardiometabolic
risk
factors.
Thus,
understanding
different
diets
their
impact
on
important
guiding
secondary
prevention
disease
(CVD).
Yet,
there
many
barriers
limitations
to
adopting
a
heart
healthy
diet.
Recent
Findings:
Diets
rich
fruits,
vegetables,
legumes,
whole
grains,
lean
protein
sources,
with
minimization/avoidance
processed
foods,
trans-fats,
sugar
sweetened
beverages,
recommended
by
guidelines.
Mediterranean,
DASH,
plant-based
have
all
proven
cardioprotective
varying
degrees
endorsed
professional
healthcare
societies,
while
other
emerging
such
as
ketogenic
intermittent
fasting
require
more
long-term
study.
effects
gut
microbiome
opened
new
path
for
precision
medicine
improve
certain
dietary
metabolites,
trimethylamine
N-oxide,
factors,
along
diversity
gene
pathways
relation
CVD
management,
being
explored.
Summary:
In
this
review,
we
provide
comprehensive
up-to-date
overview
established
health.
We
discuss
effectiveness
various
most
importantly
approaches
nutritional
counseling
where
traditional
non-traditional
practiced,
helping
patients
adopt
diets.
address
regarding
food
insecurity,
poor
access,
socioeconomic
burden.
Lastly,
need
multidisciplinary
team-based
approach,
role
nutrition
specialist,
implementing
culturally-tailored
recommendations.
Understanding
finding
ways
overcome
heart-healthy
will
take
us
miles
management.
Keywords:
disease,
diet,
guidelines,
nutrition,
disparities,
Psychiatry Research,
Год журнала:
2024,
Номер
335, С. 115866 - 115866
Опубликована: Март 20, 2024
The
ketogenic
diet
(KD,
also
known
as
metabolic
therapy)
has
been
successful
in
the
treatment
of
obesity,
type
2
diabetes,
and
epilepsy.
More
recently,
this
shown
promise
psychiatric
illness.
We
conducted
a
4–month
pilot
study
to
investigate
effects
KD
on
individuals
with
schizophrenia
or
bipolar
disorder
existing
abnormalities.
Twenty–three
participants
were
enrolled
single–arm
trial.
Results
showcased
improvements
health,
no
meeting
syndrome
criteria
by
conclusion.
Adherent
experienced
significant
reduction
weight
(12%),
BMI
waist
circumference
(13%),
visceral
adipose
tissue
(36%).
Observed
biomarker
enhancements
population
include
27%
decrease
HOMA–IR,
25%
drop
triglyceride
levels.
In
measurements,
showed
32%
Brief
Psychiatric
Rating
Scale
scores.
Overall
Clinical
Global
Impression
(CGI)
severity
improved
an
average
31%,
proportion
that
started
elevated
symptomatology
at
least
1–point
CGI
(79%).
outcomes
across
cohort
encompassed
increased
life
satisfaction
(17%)
enhanced
sleep
quality
(19%).
This
trial
underscores
potential
advantages
adjunctive
dietary
grappling
serious
mental
Abstract
Background
Systematic
reviews
and
meta-analyses
of
randomized
clinical
trials
(RCTs)
have
reported
the
benefits
ketogenic
diets
(KD)
in
various
participants
such
as
patients
with
epilepsy
adults
overweight
or
obesity
.
Nevertheless,
there
has
been
little
synthesis
strength
quality
this
evidence
aggregate.
Methods
To
grade
from
published
RCTs
that
assessed
association
KD,
low-carbohydrate
high-fat
diet
(K-LCHF),
very
low-calorie
KD
(VLCKD)
health
outcomes,
PubMed,
EMBASE,
Epistemonikos,
Cochrane
database
systematic
were
searched
up
to
February
15,
2023.
Meta-analyses
included.
re-performed
using
a
random-effects
model.
The
per
provided
was
rated
by
GRADE
(Grading
Recommendations,
Assessment,
Development,
Evaluations)
criteria
high,
moderate,
low,
low.
Results
We
included
17
comprising
68
(median
[interquartile
range,
IQR]
sample
size
42
[20–104]
follow-up
period
13
[8–36]
weeks)
115
unique
associations.
There
51
statistically
significant
associations
(44%)
which
four
supported
high-quality
(reduced
triglyceride
(
n
=
2),
seizure
frequency
1)
increased
low-density
lipoprotein
cholesterol
(LDL-C)
1))
moderate-quality
(decrease
body
weight,
respiratory
exchange
ratio
(RER),
hemoglobin
A
1c
,
total
cholesterol).
remaining
low
(26
associations)
(17
evidence.
In
obese
adults,
VLCKD
significantly
associated
improvement
anthropometric
cardiometabolic
outcomes
without
worsening
muscle
mass,
LDL-C,
cholesterol.
K-LCHF
reduced
weight
fat
percentage,
but
also
mass
healthy
participants.
Conclusions
This
umbrella
review
found
beneficial
moderate
on
several
parameters.
However,
clinically
meaningful
increase
LDL-C.
Clinical
long-term
are
warranted
investigate
whether
short-term
effects
will
translate
cardiovascular
events
mortality.